STOCK MARKET BSE NSE

Booster increases antibodies, says Johnson & Johnson

The drugmaker says researchers saw an increase in antibodies nine-fold higher than levels seen about a month after the first dose of the vaccination was administered.

Published: 25th August 2021 09:22 PM  |   Last Updated: 25th August 2021 09:24 PM   |  A+A-

Vials of Johnson & Johnson COVID-19 vaccine at a pharmacy in Denver. (File photo | AP)

By PTI

NEW BRUNSWICK: Johnson & Johnson says a booster shot of its COVID-19 vaccine appears to produce “a rapid and robust” increase in antibodies needed to fight the coronavirus.

The drugmaker says researchers saw an increase in antibodies nine-fold higher than levels seen about a month after the first dose of the vaccination was administered.

The company cited early results from studies looking at people who received the booster after getting an initial dose of J&J's single-shot vaccine.

J&J says researchers saw increases in antibodies in people ages 18 to 55 and in study participants 65 and older who received a lower booster dose.

US health officials announced last week plans to dispense COVID-19 booster shots to all Americans to shore up protection amid the surging delta variant of the virus.

Officials say the protection against infections wanes over time among various vaccines but remains strong at preventing hospitalizations and deaths.

J&J says it is talking with regulators in both the U.S. and Europe about booster shots.



Comments

Disclaimer : We respect your thoughts and views! But we need to be judicious while moderating your comments. All the comments will be moderated by the newindianexpress.com editorial. Abstain from posting comments that are obscene, defamatory or inflammatory, and do not indulge in personal attacks. Try to avoid outside hyperlinks inside the comment. Help us delete comments that do not follow these guidelines.

The views expressed in comments published on newindianexpress.com are those of the comment writers alone. They do not represent the views or opinions of newindianexpress.com or its staff, nor do they represent the views or opinions of The New Indian Express Group, or any entity of, or affiliated with, The New Indian Express Group. newindianexpress.com reserves the right to take any or all comments down at any time.

flipboard facebook twitter whatsapp